Adenovirus Early Region 1A protein (E1A)

Adenovirus Early Region 1A (E1A) is a multifunctional viral oncoprotein that serves as the primary regulator of the adenovirus life cycle by hijacking host cell machinery (Berk, 2005, PMID: 16288281). It functions as a protein-protein interaction hub, primarily targeting the Retinoblastoma (pRb) protein family and the p300/CBP transcriptional co-activators (Pelka et al., 2008, PMID: 18242885). By binding to pRb, E1A releases E2F transcription factors, forcing the host cell into the S-phase to facilitate viral DNA synthesis. Simultaneously, its interaction with p300/CBP and other chromatin remodelers reprograms the host transcriptome to suppress antiviral responses and promote viral gene expression (Gallinari et al., 1997). In oncology, the E1A-pRb interaction is exploited in the design of oncolytic viruses like Tasadenoturev (DNX-2401), which contains a 24-base pair deletion (Delta24) in the E1A gene, restricting viral replication to cancer cells with pre-existing pRb pathway defects (Fueyo et al., 2000, PMID: 10602488). While E1A itself is a viral protein, the complex it forms with host machinery represents a critical therapeutic target for both antiviral drug development and cancer virotherapy.

Other names

AdE1AEarly Region 1AE1A oncoproteinAdenovirus E1A-host protein complexHAdV E1A

Disruption of the pRb-E2F complex to induce S-phase entry and sequestration of p300/CBP to modulate host transcription and suppress antiviral defenses.